Diabetes treatment is constantly progressing, with new therapeutic options emerging to improve patient outcomes. Recent investigations have focused on GLP-1 and GIP receptor agonists, a group of drugs that mimic the https://monicacfqq708435.wikijournalist.com/28594/promising_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment